yixin-shu

composed of seven herbs, including Radix Ginseng, Fructus Schisandrae Chinensis, Radix Ophiopogonis, Astragalus Membranaceus, Salvia Miltiorrhiza, Ligusticum Wallichii, and Fructus Crataegi

Also Known As:

Networked: 4 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Guo, Feifei: 3 articles (01/2021 - 10/2017)
2.	Yang, Hongjun: 3 articles (01/2021 - 10/2017)
3.	Zhang, Jingjing: 3 articles (01/2021 - 10/2017)
4.	Zhang, Yi: 3 articles (01/2021 - 10/2017)
5.	Wei, Junying: 2 articles (01/2021 - 03/2018)
6.	Zhang, Fangbo: 2 articles (01/2021 - 10/2017)
7.	Li, Defeng: 2 articles (03/2018 - 10/2017)
8.	Gao, Jinhuan: 1 article (01/2021)
9.	Wang, Ping: 1 article (01/2021)
10.	Xiang, Changpei: 1 article (01/2021)

Related Diseases

1.	Myocardial Ischemia (Ischemic Heart Diseases) 03/11/2016 - "Here, we investigated the nature and underlying mechanisms of the effects of YiXin-Shu (YXS), an antioxidant-enriched TCM formula, on myocardial ischemia/reperfusion (MI/R) injury. " 01/01/2021 - "In this study, the protective effect of Yixin-shu (YXS) capsules, a conventional medicine for various cardiovascular diseases, against myocardial ischemia-induced HF in rats was systematically investigated by RNA-seq technology. " 03/11/2016 - "YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α."
2.	Heart Diseases (Heart Disease) 03/05/2018 - "Yixin-Shu capsules (YXS) are a Chinese Materia Medica standardized product used for heart disease and their effectiveness has been demonstrated through both clinical and experimental research. " 10/24/2017 - "In this study, an integrated strategy which integrated RNA-seq-based transcriptomics techniques and a newly developed concatenated tandem array of consensus TF response elements (catTFREs)-based proteomics approach and then combined with a network pharmacology analysis, was developed and this integrated strategy was used to investigate critical TFs in the protection of Yixin-shu (YXS), a standardized medical product used for ischaemic heart disease, against hydrogen peroxide (H2O2)-induced damage in cardiomyocytes. "
3.	Cardiovascular Diseases (Cardiovascular Disease) 01/01/2021 - "In this study, the protective effect of Yixin-shu (YXS) capsules, a conventional medicine for various cardiovascular diseases, against myocardial ischemia-induced HF in rats was systematically investigated by RNA-seq technology. "
4.	Reperfusion Injury 03/11/2016 - "YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α."
5.	Ischemia 01/01/2021 - "Yixin-Shu Capsules Ameliorated Ischemia-Induced Heart Failure by Restoring Trx2 and Inhibiting JNK/p38 Activation."

Related Drugs and Biologics

1.	RNA (Ribonucleic Acid)
2.	Hydrogen Peroxide (Hydroperoxide)
3.	Materia Medica (Homeopathic Remedies)
4.	Antioxidants
5.	Liver X Receptors
6.	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)

Related Therapies and Procedures

1.	Chinese Traditional Medicine (Traditional Chinese Medicine)